John Overdeck Two Sigma Investments
John Overdeck is a co-founder of Two Sigma Investments, one of the world’s leading quantitative and technology-driven investment firms. Two Sigma applies data science, machine learning, and large-scale computing to markets across asset classes. Overdeck’s firm is a central reference point in discussions of modern systematic investing.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$257M |
| 2 |
Boston Scientific
BSX
|
+$228M |
| 3 |
Meta Platforms (Facebook)
META
|
+$225M |
| 4 |
Amazon
AMZN
|
+$220M |
| 5 |
S&P Global
SPGI
|
+$219M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Pfizer
PFE
|
+$252M |
| 2 |
PayPal
PYPL
|
+$252M |
| 3 |
Walt Disney
DIS
|
+$217M |
| 4 |
Chevron
CVX
|
+$206M |
| 5 |
Best Buy
BBY
|
+$152M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 17.83% |
| 2 | Consumer Discretionary | 13.53% |
| 3 | Financials | 9.1% |
| 4 | Healthcare | 9.07% |
| 5 | Consumer Staples | 8.35% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2601
CALL
Abercrombie & Fitch
ANF
$4.84B
| $444K | ﹤0.01% |
21,800
-2,700
| -11% | -$49.5K |
|
2602
PUT
Helen of Troy
HELE
$673M
| $444K | ﹤0.01% |
2,000
-1,500
| -43% | -$309K |
|
|
CTO
2603
CTO Realty Growth
CTO
$823M
| $441K | ﹤0.01% |
+31,392
| New | +$414K |
|
|
SURF
2604
DELISTED
Surface Oncology, Inc. Common Stock
SURF
| $441K | ﹤0.01% |
47,755
-214,593
| -82% | -$1.87M |
|
2605
CALL
Franklin Templeton
BEN
$17.8B
| $440K | ﹤0.01% |
17,600
+6,800
| +63% | +$152K |
|
2606
CALL
The Mosaic Company
MOS
$7.72B
| $439K | ﹤0.01% |
+19,100
| New | +$385K |
|
2607
CALL
NRG Energy
NRG
$23.9B
| $439K | ﹤0.01% |
11,700
-12,400
| -51% | -$408K |
|
2608
PUT
Broadcom
AVGO
$1.7T
| $438K | ﹤0.01% |
10,000
-149,000
| -94% | -$5.81M |
|
|
ANSS
2609
PUT
DELISTED
Ansys
ANSS
| $437K | ﹤0.01% |
+1,200
| New | +$402K |
|
2610
PUT
Halliburton
HAL
$28.2B
| $437K | ﹤0.01% |
23,100
-22,500
| -49% | -$349K |
|
|
DZSI
2611
DELISTED
DZS Inc. Common Stock
DZSI
| $436K | ﹤0.01% |
28,170
+11,254
| +67% | +$141K |
|
2612
CALL
Ally Financial
ALLY
$13B
| $435K | ﹤0.01% |
+12,200
| New | +$369K |
|
2613
Oil States International
OIS
$506M
| $434K | ﹤0.01% |
86,465
+51,300
| +146% | +$199K |
|
2614
Park Aerospace
PKE
$707M
| $434K | ﹤0.01% |
32,356
-25,064
| -44% | -$308K |
|
|
SLCA
2615
DELISTED
U.S. SILICA HOLDINGS, INC.
SLCA
| $433K | ﹤0.01% |
61,697
-60,400
| -49% | -$262K |
|
2616
PUT
PACCAR
PCAR
$68B
| $431K | ﹤0.01% |
+7,500
| New | +$440K |
|
2617
PUT
Casey's General Stores
CASY
$30.5B
| $429K | ﹤0.01% |
2,400
+1,100
| +85% | +$200K |
|
2618
Harvard Bioscience
HBIO
$34.5M
| $429K | ﹤0.01% |
9,998
+4,497
| +82% | +$168K |
|
2619
Lightspeed Commerce
LSPD
$1.38B
| $429K | ﹤0.01% |
6,100
-66,200
| -92% | -$3.06M |
|
2620
PUT
Dave & Buster's
PLAY
$350M
| $429K | ﹤0.01% |
+14,300
| New | +$318K |
|
2621
CALL
CMS Energy
CMS
$21.6B
| $427K | ﹤0.01% |
7,000
+3,600
| +106% | +$225K |
|
2622
CALL
Oracle
ORCL
$417B
| $427K | ﹤0.01% |
6,600
-6,200
| -48% | -$369K |
|
2623
PUT
Molina Healthcare
MOH
$10.4B
| $425K | ﹤0.01% |
+2,000
| New | +$413K |
|
2624
CALL
Stratasys
SSYS
$693M
| $425K | ﹤0.01% |
20,500
+4,600
| +29% | +$73.8K |
|
|
FLIR
2625
CALL
DELISTED
FLIR Systems, Inc. (DE) Common Stock
FLIR
| $425K | ﹤0.01% |
9,700
-1,300
| -12% | -$50.2K |
|
Similar funds
John Overdeck's Q4 2020 Portfolio in Review
As of Q4 2020, John Overdeck held 3,971 positions worth $34.9B, up 24% from $28.2B the previous quarter. Its ten largest holdings account for 7.4% of the portfolio.
John Overdeck deployed $1.95B of net new capital in Q4 2020, opening 955 new positions and adding to 1,167 existing holdings. Its largest new stake was Boston Scientific: 6,312,819 shares worth $227M.
By sector, the portfolio is most concentrated in Technology at 18% of assets, up from 15% a quarter earlier, followed by Consumer Discretionary and Financials.
On the sell side, the largest reduction was Chevron, an estimated $206M trimmed.
- John Overdeck's largest Q4 2020 buy was Boston Scientific: 6,312,819 shares worth $227M.
- John Overdeck added most to NVIDIA in Q4 2020, an estimated $257M increase.
- John Overdeck's biggest Q4 2020 reduction was Chevron, cutting an estimated $206M.
- John Overdeck fully exited Pfizer in Q4 2020, selling an estimated $252M.
- John Overdeck's ten largest holdings make up 7.4% of its $34.9B portfolio in Q4 2020.
- John Overdeck opened 955 new positions and closed 694 in Q4 2020.
- John Overdeck's portfolio value rose 24% quarter-over-quarter to $34.9B.
Based on Two Sigma Investments's 13F filing for Q4 2020, filed 16 Feb 2021.